Alpha-synuclein -- the alpha-synuclein protein in the brain misfolds in Parkinson's
Apathy -- loss of interest,, motivation or emotional response
Bradykinesia -- slowness of movement
Carbidopa -- moderates the breakdown of levodopa outside the brain
Deep brain stimulation -- electrodes are placed in the brain to treat movement disorders associated with PD
Dystonia -- involuntary muscle contraction
Dyskinesia -- involuntary movements, the result of taking medications, not a direct symptom of PD
Dysphonia -- difficulty speaking
Dopamine -- a neurotransmitter impacted by PDs -- article -- The Science of PD
Levodopa -- primary treatment for PD, the brain converts it to dopamine
Parkinson's -- a neurodegenerative disease -- article -- The Science of PD
UPDRS -- Unified Parkinson's Disease Rating Scale
C/L -- carbidopa/levodopa -- the "standard" medication for PD
DA : dopamine agonist
DBS -- deep brain stimulation
DX -- diagnosis
MDS -- movement disorder specialist
NOH -- Neurogenic orthostatic hypotension
PD -- Parkinson's disease
PWP -- person with Parkinson's
PD -- Parkinson's disease
PDD -- Parkinson's disease dementia
PWP -- person with Parkinson's
TRAP -- Tremor,rigidity,akinesia,postural instability
YOPD -- Young onset Parkinson's disease
xx
Azilect -- brand name for rasagiline, an MAO-B inhibitor
Carbidopa/levodopa 25/100 -- generic for Sinemet, 25 mg carbidopa and 100 mg levodopa
COMT inhibitors -- medicines (as entacapone) that slow the breakdown of dopamine
Dopamine agonist -- medications (as ropinirole) that mimic the effects of dopamine
MAO-B inhibitor -- slows the breakdown of dopamine
Sinemet -- the original brand name version of carbidopa/levodopa
Opicapone (Ongentys) -- taken with carbidopa/levodopa, helps "smooth" the availability of levodopa
More information on: Levodopa
Several other medicines may be used to control the symptoms of PD.